Affinity Asset Advisors, LLC Novavax Inc Put Options Transaction History

Affinity Asset Advisors, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $845,568 - $1.83 Million	146,800 Added 73.4%	346,800 $2.4 Million
Q4 2022 Feb 13, 2023	BUY	$8.86 - $25.04 $1.77 Million - $5.01 Million	200,000 New	200,000 $2.06 Million
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $3.27 Million - $6.78 Million	90,000 New	90,000 $4.63 Million
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $3.49 Million - $7.15 Million	-50,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $6.73 Million - $10.9 Million	50,000 New	50,000 $7.15 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.